Stem cells, the word "stem", as the name suggests, are "trunk" and "origin".
Just like a tree, it can grow branches, leaves, flowers and fruits, and in the same way, stem cells have the ability to self-renew and have the potential for multi-directional differentiation. It is like a universal tool that can be differentiated into a variety of functional cells or tissues and organs. Because of this, it is also known as the "universal cell", which has made countless researchers crazy!
In the scientific community, stem cells are defined as a type of primitive cell, and as the origin cell of the body, the power of stem cells lies in its infinite possibilities and adaptability. Stem cells can be found in embryos, placenta, bone marrow, peripheral blood, and adult tissues. Under the conditions of modern biomedical technology, stem cells can be cultured into more than 200 kinds of human cells, tissues and organs, such as muscles, bones and nerves. This is the beauty of stem cells, which not only represent the infinite possibilities of life.
The birth of stem cells is likely to subvert the traditional medical concept!
Wu Zuze, an academician of the Chinese Academy of Sciences and a pioneer of stem cell research in China, believes that until now, there are still many diseases in human life that cannot be treated with drugs, so people are looking forward to a new round of medical technology revolution. And based on the repair and regeneration ability of stem cells in cells** and regenerative medicine,It is expected to become the third way of disease after drugs and surgeryand a bright future.
At present, stem cell research is accelerating around the world, and so far, eight stem cell applications have been approved worldwide, clinical studies have been carried out in more than 120 diseases, and 35,000 stem cell transplants have been performed.
The United States has elevated CGT to the national strategic level, and China has frequently mentioned stem cells in its policy, raising the cell industry to a national strategic level.
At present, China implements a dual-track system for the supervision of cells and genes, which is jointly managed by the National Medical Products Administration and the National Health Commission. There are two main ways to declare: one is to declare according to drugs, and the other is to declare according to medical technology. Although there is no stem cell drug on the market yet, a number of stem cell clinical trial projects have reached the third phase of clinical trials, and China's clinical projects are showing a concentrated outbreak trend, and it is likely that after the first drug is launched, a number of drugs will show a current situation of contention.
As a senior stem cell practitioner, I am very much looking forward to the leapfrog development in the field of stem cells. Looking forward to it, and encourage you together! February** Dynamic Incentive Program